|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.840 USD | -4.70% |
|
+2.53% | -21.33% |
| 07-28 | Altimmune, Inc. - Special Call | |
| 07-28 | Altimmune Announces Positive Topline Results from Reclaim Phase 2 Trial of Pemvidutide in Alcohol Use Disorder | CI |
| Market Cap | 552M 480M 447M 410M 775M 52.72B 787M 5.27B 2.07B 26.25B 2.07B 2.03B 88.01B | P/E 2026 * |
-4.6x | P/E 2027 * | -4.23x |
|---|---|---|---|---|---|
| Enterprise Value | 108M 93.72M 87.23M 80.09M 151M 10.29B 154M 1.03B 404M 5.12B 405M 396M 17.18B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
99.59% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Altimmune, Inc.
| 1 day | -4.70% | ||
| 1 week | +2.53% | ||
| 1 month | -9.84% | ||
| 3 months | +0.71% | ||
| 6 months | -49.29% | ||
| Current year | -21.33% |
| 1 week | 2.78 |  | 3.31 |
| 1 month | 2.75 | | 3.31 |
| Current year | 2.56 | | 6.44 |
| 1 year | 2.56 | | 6.44 |
| 3 years | 2.09 | | 14.84 |
| 5 years | 2.09 | | 23.49 |
| 10 years | 1.51 | | 237.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jerome Durso
CEO | Chief Executive Officer | 58 | 01/01/2026 |
Gregory Weaver
DFI | Director of Finance/CFO | 70 | 11/11/2024 |
Rachel Garner
CTO | Chief Tech/Sci/R&D Officer | - | 01/05/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Philip Hodges
BRD | Director/Board Member | 58 | 01/09/2003 |
Mitchel Sayare
CHM | Chairman | 78 | 01/01/2018 |
Klaus Schafer
BRD | Director/Board Member | 76 | 01/07/2012 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 26/02/26 | Free | Chief Technology Officer | 318,100 | 0.2540% | ||
| 26/02/26 | Free | Chief Financial Officer | 370,000 | 0.2955% | ||
| 31/01/26 | Free | Executive/Senior Manager | 4,571 | 0.0044% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.70% | +2.53% | -21.33% | -10.41% | 552M | |
| +2.35% | +2.74% | +38.10% | +71.29% | 56.54B | |
| -0.21% | -7.38% | +27.52% | +61.15% | 53.6B | |
| -2.44% | +1.40% | -15.61% | -15.45% | 22.91B | |
| -2.85% | -7.78% | -9.28% | +345.55% | 21.37B | |
| +2.49% | -0.92% | +23.57% | -13.14% | 20.27B | |
| +0.79% | -1.06% | +33.99% | -31.95% | 17.56B | |
| +0.58% | -5.88% | +19.40% | +527.50% | 14.75B | |
| +3.41% | -6.61% | +162.81% | +278.22% | 13.53B | |
| -5.25% | -4.23% | +42.32% | +170.15% | 13.33B | |
| Average | -0.58% | -3.16% | +30.15% | +138.29% | 23.44B | |
| Weighted average by Cap. | +0.22% | -2.95% | +30.67% | +116.54% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -107M -92.97M -86.54M -79.45M -150M -10.21B -152M -1.02B -400M -5.08B -402M -393M -17.04B | -130M -113M -105M -96.59M -182M -12.41B -185M -1.24B -487M -6.18B -488M -478M -20.72B |
| Net Debt | -444M -386M -360M -330M -624M -42.43B -633M -4.24B -1.66B -21.12B -1.67B -1.63B -70.83B | -340M -295M -275M -252M -477M -32.44B -484M -3.24B -1.27B -16.15B -1.28B -1.25B -54.15B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/07/26 | $2.840 | -4.70% | 3,892,079 |
| 30/07/26 | $2.980 | +2.05% | 5,439,362 |
| 29/07/26 | $2.920 | -2.34% | 8,301,360 |
| 28/07/26 | $2.990 | +1.01% | 17,142,614 |
| 27/07/26 | $2.960 | +6.86% | 4,060,013 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ALT Stock
Select your edition
All financial news and data tailored to specific country editions
